tirzepatide retinopathy The popular #diabetes and weight loss medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic #retinopathy, a leading cause of vision loss, according to Dr. Szilárd Kiss and Early worsening of diabetic retinopathy

Outcomes vary: Mild cases may improve with treatment Moderate cases may require long-term management Severe cases can become permanent Some patients develop lifelong GI dysfunction after GLP-1 drug use Early diagnosis significantly improves prognosis

Week 0: Take final dose of Semaglutide (Wegovy/Ozempic) Week 1: Begin Tirzepatide at 2.5mg Week 5+: Follow standard Tirzepatide escalation protocol Note: Start at the lowest Tirzepatide dose regardless of previous Semaglutide dose Even patients on maximum Semaglutide doses should start Tirzepatide at 2.5mg

Following Doctors Orders Always adhere to the instructions given by your healthcare provider

Do you see this changing how obesity treatment is positioned with patients and employers.

This combination of effects is the reason why oral semaglutide near you in Tennessee is a valuable tool for achieving meaningful, sustained weight loss

About TRIUMPH-4 and the TRIUMPH clinical trial program TRIUMPH-4 (NCT05931367) is a Phase 3, 68-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with obesity or overweight and knee osteoarthritis